Respiratory Infections

In a new study, Centers for Disease Control and Prevention (CDC) researchers have found that getting the flu shot reduces the risk of influenza-associated pediatric deaths.

News on Heliobacter pylori, Zika, Clostridium difficile, Powassan virus, and influenza make up the top 5 news articles from Contagion® in March 2017.

During a recent webcast lecture, Hana Golding, PhD from the US Food and Drug Administration described new ways to evaluate safety and effectiveness of vaccine adjuvants.

Matt Linam, MD, MS, Assistant Professor, Pediatric Infectious Diseases, University of Arkansas for Medical Sciences, explains the best ways to reduce the number of respiratory viral healthcare-associated infections in children.

On March 30, 2017, at the SHEA Spring 2017 Conference, Matt Linam, MD, MS, discussed strategies to prevent healthcare workers from spreading healthcare-associated infections (HAIs).

Researchers suggest that patients with eczema should request that their flu shots be administered intramuscularly and not intradermally.

Although cases of influenza A are on the decline, a late season surge in influenza B cases are helping to extend flu season across parts of the United States.

In case you missed them, our top 5 articles for the week of March 19, 2017 are highlighted here.

The results of a new study have revealed that older women and African Americans are less likely to get vaccinated against influenza.

As we reflect on the progress made in the fight against tuberculosis (TB), the Centers for Disease Control and Prevention stress that without actions to accelerate progress, the goal of eliminating TB in the United States by the end of the century will not be met.

Flu activity continues to drop across the country, but new outbreaks continue as health officials predict a flu season that could last until May in some areas.

In case you missed them, our top 5 articles for the week of March 12, 2017 are highlighted here.

The United States has likely seen its flu season peak, although health officials around the country are issuing reminders that new illnesses and flu-related deaths may continue for several weeks.

As healthcare-associated infections continue to be life-threatening, Clorox Healthcare continues to provide bacteria- and virus-killing products that aim to reduce the risk of infection.

Dental plaque may be a culprit in the development of pneumonia, but better oral health can mitigate that risk both in ventilated hospital patients and in healthy individuals.

In late February, the World Health Organization (WHO) released its first list of Priority Pathogens, for which research and development is strongly needed. Not included on the list is tuberculosis, which has been acknowledged as one of the leading killers around the world. Naturally, many individuals working in public health and infectious disease are objecting to the exclusion.

A high-dose flu vaccine may offer more protection to older adults during flu seasons in which Influenza A(N2N3) is circulating.

The Centers for Disease Control and Prevention (CDC) has reported six new flu-related pediatric deaths, including one confirmed by health officials in Milwaukee.

Did you read this week’s top infectious disease news coverage from Contagion®?

Pharmacists can play an important role in managing the use of these medications in patients, particularly those with high blood pressure.

A decrease in flu activity in the United States brings some relief to a flu season marked by severe illness, but health officials say that the season may last for several more weeks.

Catch up on last month's top infectious disease news coverage from Contagion®.

The results of a new study suggest a 3-7% increase in the likelihood of having a heart attack in some patients with acute respiratory infections also takes nonsteroidal anti-inflammatory drugs (NSAIDs).

A new report from the Centers for Disease Control and Prevention (CDC) details just how effective the flu shot has been so far this season.

A team of researchers has developed single-domain antibodies that remain stable and stop respiratory syncytial virus (RSV) from entering the lungs.